Status | Study |
Recruiting |
Study Name: A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH Condition: Syndrome of Inappropriate Antidiuretic Hormone Secretion Date: 2017-02-07 Interventions: Drug: Tolvaptan Oral Tablet Tolvaptan tablets at 7.5, 15, 30 (one tablet each), or 60 mg (two 30 mg tabl |
Enrolling by invitation |
Study Name: Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study Condition: SIADH Date: 2016-08-17 Interventions: Drug: Empagliflozin Other: Placebo |
Completed |
Study Name: Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study Condition: Inappropriate ADH Syndrome Date: 2016-03-24 Interventions: Other: Induced hypotonic hyponatremia - SIAD model |
Recruiting |
Study Name: An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy Condition: Hyponatremia Syndrome of Inappropriate ADH (SIADH) Secretion Date: 2015-10-06 |
Completed |
Study Name: An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain Condition: Hyponatremia Syndrome of Inappropriate ADH (SIADH) Secretion Date: 2015-09-07 |
Completed |
Study Name: An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH Condition: Hyponatremia Syndrome of Inappropriate ADH (SIADH) Secretion Date: 2015-09-07 |
Completed |
Study Name: A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Condition: Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Date: 2013-12-09 Interventions: Drug: tolvaptan Subjects will receive a single dose of 3.75, 7.5 or 15 mg of tolvaptan on study Day 1 |
Completed |
Study Name: Subclassification of the Syndrome of Inappropriate ADH Secretion Condition: Hyponatremia Date: 2011-04-21 |
Terminated |
Study Name: Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia Condition: Hyponatremia Dilutional Hyponatremia Date: 2010-10-22 Interventions: Drug: tolvaptan 15 mg titrated |
Terminated |
Study Name: A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia Condition: Hyponatremia Inappropriate ADH Syndrome Date: 2008-07-31 Interventions: Drug: Satavaptan tablets |